09140967 · Active · incorporated 12 years ago · Oxford
Biotech Biotech & Life Sciences Drug Discovery Series A
DJS Antibodies develops next-generation antibody therapeutics using its HEPTAD platform to treat chronic inflammatory diseases.
https://www.djsantibodies.com/
See the complete cap table with every shareholder, founder tags, dilution across 10 share allotments, round-by-round fundraising history, and the full filing timeline — parsed from official Companies House documents.
Create a free account Sign inFree accounts open 3 companies in full detail — no card required.